Decline in railway ridership due to the occurrence and spread of infectious diseases
First written in FY2016. 7 of 21 entries say "Restated". Latest entry: FY2025.
West Japan Railway Company moved to the "Worse" side of this theme in 2020.
1 other company's latest entry also says "Restated".
- FY2025RestatedAnnual report
「If an infectious disease were to emerge and spread, business continuity across our Group, including railway operations, could be threatened by customers refraining from going out and employees becoming infected, potentially having a major impact on business performance.」
Continues to describe the potential impact of an infectious disease outbreak on usage, employee infections, business continuity, and performance. - FY2024MitigatedAnnual report
「During the COVID-19 pandemic, when the novel coronavirus emerged and spread, our Group used stockpiled medical supplies such as masks, prepared in response to past infectious disease outbreaks, and BCP timetables for railway operations, enabling us to limit the impact on business continuity.」
As a record of responding to infectious disease risks, states that the impact on business continuity was minimized through the use of stockpiled medical supplies and BCP timetables. - FY2024-Q3MitigatedAnnual report
「During the nine months ended the third quarter of the fiscal year under review, customer usage and personal consumption recovered, while inbound demand also remained strong.」
Regarding the risk of lower usage due to the infectious disease, describes the recovery in customer usage and personal consumption and the strength of inbound demand. - FY2024-Q2MitigatedAnnual report
「During the six months ended the second quarter of the fiscal year under review, customer usage and personal consumption recovered as the impact of the novel coronavirus diminished, while inbound demand also remained strong.」
Regarding the risk of lower usage due to the novel coronavirus, describes the diminishing impact and the recovery in customer usage and personal consumption. - FY2024-Q1MitigatedAnnual report
「During the first quarter of the fiscal year under review, as customer usage and personal consumption recovered with the diminishing impact of the novel coronavirus, we implemented structural reforms such as cost reductions and measures to stimulate demand.」
Regarding the risk of lower usage due to the novel coronavirus, describes the diminishing impact and the recovery in usage and personal consumption. - FY2023MitigatedAnnual report
「In this regard, by using stockpiled medical supplies such as masks, prepared in response to past infectious disease outbreaks, and BCP timetables for railway operations, we were able to limit the impact on business continuity.」
As a response to infectious disease risks, describes the use of stockpiled medical supplies and BCP timetables, and states that the impact on business continuity was limited. - FY2023-Q3Turned profitable for the nine months ended the third quarterAnnual report
「During the nine months ended the third quarter of the fiscal year under review, operating revenue rose 33.5% year on year to ¥974.8 billion, operating income was ¥69.9 billion, and ordinary income was ¥59.8 billion, reflecting the recovery in customer usage and personal consumption as the impact of the novel coronavirus diminished. In addition, under a tax incentive based on the business adaptation plan certified in April, we recorded ¥43.5 billion in previously unrecognized deferred tax assets related to tax loss carryforwards, resulting in net income attributable to owners of the parent for the quarter, after income taxes and other taxes, of ¥87.3 billion.」
As the impact of the infectious disease diminished and usage and personal consumption recovered, operating income, ordinary income, and net income attributable to owners of the parent for the quarter turned positive for the nine months ended the third quarter. The impact of the infectious disease remains uncertain, however. - FY2023-Q2Return to profitability for the second-quarter cumulative periodAnnual report
「During the six months ended the second quarter of the fiscal year under review, operating revenue rose 41.2% year on year to ¥616.7 billion, operating income was ¥33.8 billion, and ordinary income was ¥27.7 billion, reflecting the recovery in customer usage as the impact of the novel coronavirus diminished. In addition, under a tax incentive based on the business adaptation plan certified in April, we recorded ¥43.5 billion in previously unrecognized deferred tax assets related to tax loss carryforwards, resulting in net income attributable to owners of the parent for the quarter, after income taxes and other taxes, of ¥64.5 billion.」
As the impact of the infectious disease diminished and usage recovered, operating revenue rose 41.2% year on year, and operating income, ordinary income, and net income attributable to owners of the parent for the quarter turned positive for the six months ended the second quarter. The infectious disease risk itself continues, however. - FY2023-Q1Turned profitable for the first quarter-to-date periodAnnual report
「During the first quarter of the fiscal year under review, operating revenue rose 47.1% year on year to ¥297.1 billion, operating income was ¥19.5 billion, and ordinary income was ¥16.9 billion, reflecting the recovery in customer usage as the impact of the novel coronavirus diminished. In addition, under a tax incentive based on the business adaptation plan certified in April, we recorded ¥43.5 billion in previously unrecognized deferred tax assets related to tax loss carryforwards, resulting in net income attributable to owners of the parent for the quarter, after income taxes and other taxes, of ¥57.8 billion. Meanwhile, the impact of the novel coronavirus is expected to continue.」
Although the risk of lower usage due to the novel coronavirus is expected to continue, the recovery in usage resulted in positive operating income, ordinary income, and net income attributable to owners of the parent for the quarter on a first-quarter cumulative basis. - FY2022Full-year performance improvementAnnual report
「Operating revenue rose 12.1% year on year to ¥1,031.1 billion, but operating loss was ¥119.0 billion, ordinary loss was ¥121.0 billion, and net loss attributable to owners of the parent for the year, after income taxes and other taxes, was ¥113.1 billion.」
Although lower usage due to the novel coronavirus continued, full-year operating revenue increased and the amount of loss declined from the previous fiscal year. - FY2022-Q3Improved performance in the third quarterAnnual report
「During the nine months ended the third quarter of the fiscal year under review, our Group's businesses remained in extremely difficult conditions due to the prolonged impact of the novel coronavirus, including the issuance and extension of the state of emergency and the rapid spread of new variants, with lower tourism usage, reduced business travel and other forms of discretionary travel, and weaker consumption. Operating revenue rose 12.0% year on year to ¥729.9 billion, but operating loss was ¥79.4 billion, ordinary loss was ¥82.6 billion, and net loss attributable to owners of the parent for the quarter, after income taxes and other taxes, was ¥54.0 billion. In contrast, during the third quarter, infection levels settled to some extent, demand recovered as various restrictions were eased following the lifting of the state of emergency, and costs were reduced by cancelling or postponing non-urgent initiatives. As a result, operating revenue rose 17.5% year on year to ¥293.1 billion, operating income was ¥6.6 billion, ordinary income was ¥4.8 billion, and net income attributable to owners of the parent for the quarter, after income taxes and other taxes, was ¥14.6 billion, indicating an improvement in performance.」
Although lower tourism and business travel demand and weaker consumption due to the novel coronavirus continued during the cumulative period, operating income, ordinary income, and net income for the quarter turned positive in the third quarter as demand recovered. - FY2022-Q1RestatedAnnual report
「During the first quarter of the fiscal year under review, our Group's businesses remained in extremely difficult conditions due to the impact of the novel coronavirus, including lower tourism usage, reduced business travel and other forms of discretionary travel, and weaker consumption.」
States that lower tourism demand, business travel demand, and consumption due to the infectious disease continue to affect the business. - FY2021MaterialisedAnnual report
「During the fiscal year under review, operating revenue fell 40.4% year on year to ¥898.1 billion, reflecting a substantial decline in revenue, particularly in the transportation business, due to lower usage associated with the spread of the novel coronavirus. Operating loss was ¥245.5 billion, ordinary loss was ¥257.3 billion, and net loss attributable to owners of the parent for the year, after income taxes and other taxes, was ¥233.2 billion.」
The infectious disease risk appeared in full-year results not only as lower usage, but also as a 40.4% decline in operating revenue and the recording of operating, ordinary, and net losses. - FY2021-Q3RestatedAnnual report
「With the resurgence of the novel coronavirus and the resulting suspension of the Go To Travel Campaign, among other factors, a recovery in usage over the short term cannot be foreseen, and we recognize this as the greatest financial crisis since the Company's establishment.」
Continues to describe the inability to foresee a recovery in usage due to the resurgence of the novel coronavirus and the suspension of the travel campaign. - FY2021-Q2RestatedAnnual report
「During the second quarter of the fiscal year under review, the spread of the novel coronavirus had a major impact on socioeconomic activity worldwide, including in Japan. Our Group's businesses were also placed in extremely difficult conditions after the declaration of a state of emergency, including lower tourism usage, reduced business travel and other forms of discretionary travel, and weaker consumption.」
Lower usage, reduced business travel, and weaker consumption resulting from the novel coronavirus infection continue to occur. - FY2021-Q1MaterialisedAnnual report
「During the first quarter of the fiscal year under review, the spread of the novel coronavirus had a major impact on socioeconomic activity worldwide, including in Japan. Our Group's businesses were also placed in extremely difficult conditions, including lower tourism usage, reduced business travel and other forms of discretionary travel, and weaker consumption. Operating revenue fell 55.3% year on year to ¥163.3 billion, operating loss was ¥94.2 billion, ordinary loss was ¥99.7 billion, and net loss attributable to owners of the parent for the quarter, after income taxes and other taxes, was ¥76.7 billion.」
The infectious disease risk previously anticipated actually materialized as lower tourism and business travel demand, weaker consumption, a substantial decline in operating revenue, and losses resulting from the novel coronavirus infection. - FY2020MaterialisedAnnual report
「The novel coronavirus pandemic has had a major impact on economic activity overall, and our Group is also facing extremely difficult conditions, including lower tourism usage, reduced business travel and other forms of discretionary travel, and weaker consumption.」
The infectious disease risk had previously assumed SARS and similar diseases, but the novel coronavirus infection actually emerged in 2020 in the form of lower usage, reduced business travel, weaker consumption, and deteriorating performance. - FY2019RestatedAnnual report
「If an infectious disease such as SARS (severe acute respiratory syndrome) or a highly virulent novel influenza were to spread across western Japan for an extended period, economic activity could be restricted and customers could refrain from going out, potentially affecting the performance of our Group.」
Continues to describe the potential for lower usage and performance impacts resulting from an infectious disease outbreak. - FY2018RestatedAnnual report
「If an infectious disease such as SARS (severe acute respiratory syndrome) or a highly virulent novel influenza were to spread across western Japan for an extended period, economic activity could be restricted and customers could refrain from going out, potentially affecting the performance of our Group.」
Continues to describe the potential for lower usage and performance impacts resulting from an infectious disease outbreak, as before. - FY2017RestatedAnnual report
「If an infectious disease such as SARS (severe acute respiratory syndrome) or a highly virulent novel influenza were to spread across western Japan for an extended period, economic activity could be restricted and customers could refrain from going out, potentially affecting the performance of our Group.」
Continues to describe the potential for lower usage and performance impacts resulting from an infectious disease outbreak, as before. - FY2016First statedAnnual report
「If an infectious disease such as SARS (severe acute respiratory syndrome) or a highly virulent novel influenza were to spread across western Japan for an extended period, economic activity could be restricted and customers could refrain from going out, potentially affecting the performance of our Group.」
Describes restrictions on economic activity, reduced outings, and potential performance impacts resulting from an infectious disease outbreak as risks, and outlines transportation responses through cooperation with the government and local authorities.